PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34234118-6 2021 Notably, knockdown of MYBL2 sensitized CRC cells to treatment with MK-1775, a clinical trial drug for inhibition of WEE1, which is involved in a degradation pathway of RRM2. adavosertib 67-74 ribonucleotide reductase M2 Mus musculus 168-172